Likewise, in a study in which β2AR agonists, anticholinergics, corticosteroids, COPD, and multiple other covariates related to smoking were mutually adjusted for, the inverse association of β2AR agonists with PD risk remained unchanged compared to the model without these adjustments [12,28]. Here, ADRB2 is linked to Parkinson disease.